Business Context and Reporting Period
Company: Richardson Electronics, Ltd. (RELL)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended May 30, 2026 (52 weeks)
Business Overview: A global manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and customized display solutions. The Company operates three reportable segments: Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. In January 2025, the Company sold a substantial portion of its Healthcare business assets to DirectMed Imaging, LLC, integrating remaining Healthcare operations into the PMT segment.
Key Financial Metrics
| Metric | Fiscal 2026 | Fiscal 2025 | Change |
|---|---|---|---|
| Net Sales | $228.6 million | $208.9 million | +9.4% |
| Gross Profit | $71.3 million | $64.8 million | +10.1% |
| Gross Margin | 31.2% | 31.0% | +0.2 pts |
| Operating Income | $6.5 million | ($2.5 million) Loss | Turnaround |
| Net Income | $6.4 million | ($1.1 million) Loss | Turnaround |
| Cash and Equivalents | $31.8 million | $35.9 million | -$4.1 million |
| Operating Cash Flow | $0.8 million | $10.6 million | -$9.8 million |
| Debt (Revolving Credit) | $0 | $0 | — |
Liquidity: The Company maintains a $20 million revolving credit facility with PNC Bank, extended through October 2028. No borrowings were outstanding as of May 30, 2026. The Company paid $3.4 million in dividends during fiscal 2026.
Material Changes vs. Prior Period
- Profitability Turnaround: The Company returned to profitability, reporting $6.4 million in net income compared to a $1.1 million net loss in fiscal 2025. This was driven by a $5.1 million loss on the disposal of Healthcare assets in fiscal 2025, which was replaced by a $0.8 million gain on disposal of remaining Healthcare assets in fiscal 2026.
- Revenue Growth: Consolidated net sales increased 9.4% to $228.6 million. All three segments contributed to growth: PMT (+9.1%), GES (+7.3%), and Canvys (+12.4%).
- Operating Cash Flow Decline: Despite higher net income, operating cash flow decreased significantly to $0.8 million from $10.6 million. This was primarily due to an $8.9 million increase in accounts receivable and a $2.3 million increase in prepaid expenses, offsetting non-cash adjustments.
- Segment Realignment: The Company reduced its reportable segments from four to three, consolidating the remaining Healthcare operations into the PMT segment following the asset sale to DirectMed.
Guidance, Outlook, and Risks
Management Commentary: Management attributes sales growth to strong performance in RF and Wireless Components, Semiconductor Wafer Fab markets, and new customer acquisition in Green Energy Solutions. The Company continues to mitigate tariff impacts through supplier and customer collaboration.
Risks and Contingencies:
- Customer Concentration: One customer in the PMT segment accounted for 14% of consolidated net sales in fiscal 2026 ($31.5 million).
- Supplier Concentration: Two suppliers each represented more than 10% of total cost of sales in fiscal 2026.
- Inventory Obsolescence: The Company maintains significant inventory levels for trailing-edge technology products. A critical audit matter identified the estimation of obsolete or slow-moving inventory reserves as a high-judgment area.
- Geopolitical and Trade Risks: Operations are subject to tariffs on imports from China, currency exchange fluctuations (60% of sales are international), and geopolitical conflicts in Europe and the Middle East.
- Cybersecurity: The Company faces evolving cyber threats and data privacy compliance obligations (GDPR, CCPA).
Investor Verification Checklist
- Accounts Receivable Quality: Verify the collectability of the $33.2 million receivable balance, which increased by $9.0 million year-over-year, driving the decline in operating cash flow.
- Inventory Valuation: Review the $6.3 million inventory reserve and the assumptions used to value trailing-edge technology products in the PMT segment.
- Customer Dependency: Assess the stability of the relationship with the single customer representing 14% of total sales.
- Healthcare Transition: Confirm the execution and financial impact of the exclusive 10-year supply agreement with DirectMed Imaging for repaired CT tubes.
- Tax Position: Review the $2.8 million valuation allowance on deferred tax assets and the realizability of state and foreign Net Operating Losses (NOLs).